Percutaneous Intervention in ST-Elevation Myocardial Infarction: Culprit-only or Complete Revascularization?
- PMID: 29185617
- PMCID: PMC5783441
- DOI: 10.5935/abc.20170174
Percutaneous Intervention in ST-Elevation Myocardial Infarction: Culprit-only or Complete Revascularization?
Abstract
The best approach of multivessel coronary artery disease in the context of acute myocardial infarction with ST segment elevation and primary percutaneous coronary intervention is one of the main reasons for controversy in cardiology. Although the main global guidelines do not recommend routine complete revascularization in these patients, recent randomized clinical trials have demonstrated benefit of this approach in reducing cardiovascular outcomes. For this reason, an adequate review of this evidence is essential in order to establish scientifically based strategy and achieve better outcomes for these patients who present with acute myocardial infarction. This review aims to present objectively the most recent evidence available on this topic.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Similar articles
-
PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.J Am Coll Cardiol. 2016 Sep 6;68(10):1066-81. doi: 10.1016/j.jacc.2016.05.086. J Am Coll Cardiol. 2016. PMID: 27585512 Review.
-
Culprit versus multivessel coronary intervention in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.Coron Artery Dis. 2018 Mar;29(2):151-160. doi: 10.1097/MCA.0000000000000578. Coron Artery Dis. 2018. PMID: 29120880
-
Complete versus culprit-only revascularization for ST-segment-elevation myocardial infarction and multivessel disease: a meta-analysis and trial sequential analysis of randomized trials.Circ Cardiovasc Interv. 2015 Apr;8(4):e002142. doi: 10.1161/CIRCINTERVENTIONS.114.002142. Circ Cardiovasc Interv. 2015. PMID: 25873730
-
Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease.Intern Emerg Med. 2016 Jun;11(4):499-506. doi: 10.1007/s11739-016-1419-5. Epub 2016 Mar 7. Intern Emerg Med. 2016. PMID: 26951188 Review.
-
Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry.Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):425-432. doi: 10.1016/j.rec.2016.09.027. Epub 2016 Nov 4. Rev Esp Cardiol (Engl Ed). 2017. PMID: 27825718 English, Spanish.
Cited by
-
The predictive value of neutrophil-lymphocyte ratio combined with the Global Registry of Acute Coronary Events score for inhospital adverse cardiovascular events in patients with acute ST-elevation myocardial infarction.J Res Med Sci. 2024 Jul 30;29:41. doi: 10.4103/jrms.jrms_485_22. eCollection 2024. J Res Med Sci. 2024. PMID: 40224193 Free PMC article.
-
Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review.Front Pharmacol. 2018 Apr 26;9:428. doi: 10.3389/fphar.2018.00428. eCollection 2018. Front Pharmacol. 2018. PMID: 29755358 Free PMC article. Review.
References
-
- Toma M, Buller CE, Westerhout CM, Fu Y, O'Neill WW, Holmes DR, et al. APEX-AMI Investigators Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction insights from the APEX-AMI trial. Eur Heart J. 2010;31(14):1701–1707. doi: 10.1093/eurheartj/ehq129. - DOI - PubMed
-
- Sorajja P, Gersh BJ, Cox DA, McLaughlin MG, Zimetbaum P, Costantini C, et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J. 2007;28(14):1709–1716. doi: 10.1093/eurheartj/ehm184. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases